Close

Caris & Co Upgrades Par Pharmaceutical (PRX) to Buy

August 5, 2010 8:40 AM EDT Send to a Friend
Caris & Co upgrades Par Pharmaceutical (NYSE: PRX) from Above Average to Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login